Galiano Gold GAU Q1 2026 Results Fall Short EPS 011 Revenue NA Regeneron Shares Slide After Phase 3 Melanoma Trial Failure Market Weighs Pipeline Impact Enliven Therapeutics ELVN Delivers Q1 2026 Beat EPS 038 vs 047 Expected Arcadia Biosciences RKDA Crushes Q3 2025 Estimates EPS 062 Tops Views